Antihyperlipidaemic Agents : i. β-Sitosterol ii. Dextrothyroxine iii. Ezetimibe - Synthesis and Drug Profile
Miscellaneous Agents Properties and uses: β-sitosterol lowers plasma concentrations of LDL, and has no effect on VLDL. The sitosterol is believed to lower plasma levels of cholesterol by interfering with its absorption. It is used as an anticholesteremic agent and also used in the treatment of prostatic adenoma. Synthesis Uses: Used as antihyperlipidaemic agent. Metabolism of ezetimibe: It is metabolized rapidly and extensively in the intestinal wall and the liver to its active metabolite, a corresponding phenol glucuronide. This glucuronide is re-excreted in the bile back to its active site. A small amount of Ezetimibe undergoes oxidation to convert the benzylic hydroxyl group to a ketone. Ezetimibe does not appear to exert any significant effect on the activity of CYP450 enzyme. Uses: Used as an antihyperlipidaemic agent.SYNTHESIS AND DRUG PROFILE
i. β-Sitosterol
ii. Dextrothyroxine
iii. Ezetimibe
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.